Abstract
We stably transfected human kidney embryonic 293 cells with the rat neuronal nicotinic acetylcholine receptor (nAChR) α3 and β4 subunit genes. This new cell line, KXα3β4R2, expresses a high level of the α3/β4 receptor subtype, which binds (±)- [3H]epibatidine with aK d value of 304±16 pm and a B max value of 8942 ± 115 fmol/mg protein. Comparison of nicotinic drugs in competing for α3/β4 receptor binding sites in this cell line and the binding sites in rat forebrain (predominantly α4/β2 receptors) revealed marked differences in theirK i values, but similar rank orders of potency for agonists were observed, with the exception of anatoxin-A. The affinity of the competitive antagonist dihydro-β-erythroidine is >7000 times higher at α4/β2 receptors in rat forebrain than at the α3/β4 receptors in these cells. The α3/β4 nAChRs expressed in this cell line are functional, and in response to nicotinic agonists, 86Rb+ efflux was increased to levels 8–10 times the basal levels. Acetylcholine, (−)-nicotine, cytisine, carbachol, and (±)-epibatidine all stimulated86Rb+ efflux, which was blocked by mecamylamine. The EC50 values for acetylcholine and (−)-nicotine to stimulate 86Rb+ effluxes were 114 ± 24 and 28 ± 4 μm, respectively. The rank order of potency of nicotinic antagonists in blocking the function of this α3/β4 receptor was mecamylamine >d-tubocurarine > dihydro-β-erythroidine > hexamethonium. Mecamylamine, d-tubocurarine, and hexamethonium blocked the function by a noncompetitive mechanism, whereas dihydro-β-erythroidine blocked the function competitively. The KXα3β4R2 cell line should prove to be a very useful model for studying this subtype of nAChRs.
Footnotes
- Received November 18, 1997.
- Accepted May 11, 1998.
-
Send reprint requests to: Dr. Kenneth J. Kellar, Department of Pharmacology, Georgetown University School of Medicine, Washington, D.C. 20007. E-mail:kellark{at}gunet.georgetown.edu
-
This work was supported by National Institutes of Health Grants DA06486 and AG09973. E.L.M. was supported by National Institutes of Health Predoctoral Fellowship Grant DA05739–01.
-
A preliminary report of this work has been presented previously [Xiao Y, Meyer EL, Thompson JM, and Kellar KJ (1997) Generation and characterization of a stably transfected cell line expressing rat α3β4 neuronal nicotinic acetylcholine receptors. Soc Neurosci Abstr 23:385].
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
